Immunopharmacological profile of a novel isoxazol derivative, HWA 486, with potential antirheumatic activity - I. Disease modifying action on adjuvant arthritis of the rat

International Journal of Immunopharmacology

Volumn 7, Issue 1, 1985, Pages 7-18

  Bartlett, Robert R ^a   Schleyerbach, Rudolf ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; INDOMETACIN; ISOXAZOLE DERIVATIVE; LEFLUNOMIDE; NAPROXEN; PHENYLBUTAZONE;

ADJUVANT DISEASE; ANIMAL MODEL; DRUG EFFICACY; JOINT; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMAL; ANTI-INFLAMMATORY AGENTS; ARTHRITIS; ARTHRITIS, EXPERIMENTAL; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; LYMPHOCYTE ACTIVATION; MALE; OXAZOLES; RATS; RATS, INBRED LEW;

EID: 0021957656     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/0192-0561(85)90003-7     Document Type: Article

References (21)

1. Splenic suppressor cells in adjuvant arthritic rats: effect of D-penicillamine
2. The effect of some antirheumatic drugs in vivo on the response of spleen cells to concavalin-A in rats with chronic inflammation
3. Adjuvant polyarthritis. IV. Induction by a synthetic adjuvant: immunologic, histopathologic, and other studies
4. Adjuvant polyarthritis. V. Induction by N-acetyl-muramyl-L-alanyl-D-isoglutamine, the smallest peptide subunit of bacterial peptidoglycan
5. Suppression of adjuvant disease in the rat by heterologous antilymphocyte globulin
6. Response of human thymus-derived (T) and non-thymus-derived (B) lymphocytes to mitogenic stimulation in vitro
7. Drugs which apparently affect the rheumatoid disease process
8. Adjuvant-induced arthritis in four inbred strains of rats. An in vitro study of peripheral T and B lymphocytes
9. Preparation of various fractions from mycobacterium smegmatis, their arthritogenicity, and their preventive effect on adjevant disease
10. Restoration of diminished T-cell function in adjuvant induced disease by methotrexate
11. Immunologic reactivity in rheumatoid arthritis, response to mitogens
12. Suppression of rat adjuvant disease by cyclophosphamide pretreatment; evidence for an antibody mediated component in the pathogenesis of the disease
13. Development of arthritis periarthritis and periostitis and periostitis in rats given adjuvants
14. Passive transfer of adjuvant arthritis by lymph node or spleen cells
15. The use of a standardized adjuvant arthritis assay to differentiate between anti-inflammatory and immunosuppressive agents
16. Abnormalities of peripheral blood lymphocytes in rheumatoid arthritis
17. Lymphocytes in rheumatoid arthritis. I. response to allogenic cells and to phytomitogens
18. Stimulation of lymphocytes from rheumatoid arthritis patients by mitogens and IgG
19. Review/Commentary. The Immunopharmacology of Cyclophosphamide
20. Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant II evidence that the disease is a disseminated immunologic response to exogenous antigen
21. Adjuvant-induced arthritis in rats. II. Drug effects on physiologic, biochemical, and immunologic parameters